• Management of women with postpartum pre-eclampsia
en To content

Management of women with postpartum pre-eclampsia

HEALTH OF WOMAN. 2019.9(145): 8–13; doi 10.15574/HW.2019.145.8
I.V. Lakhno
Kharkiv medical Academy of postgraduate education

Pre-eclampsia found only in humans during the second half of pregnancy or the postpartum period, is known to be featured by the development of arterial hypertension and multiple organ failure syndrome. Almost a third of eclampsia is known to occur in the postpartum period. The pre-eclamptic patients require thorough monitoring of blood pressure and administration of antihypertensive drugs in the puerperium.

The pathogenesis and tactics of the developed de novo postpartum pre-eclampsia have not been sufficiently studied. The greatest risk of stroke after delivery remains for 10 days. In the case of postpartum pre-eclampsia, it is very important to start using antihypertensives in a timely manner. First-line drugs should be used not later than 30-60 minutes from the time of severe pre-eclampsia diagnosing to prevent intracranial hemorrhage. Labetalol or hydralazine should be used in order to reduce blood pressure. Sublingual administration of nifedipine may also be considered as first-line therapy. The use of magnesium sulfate is necessary for the prevention of seizures in patients with severe preeclampsia. In the case of eclampsia, a solution of magnesium sulfate is administered intravenously at a loading dose of 4-5 g for 15-20 minutes and then continued infusion at a dose of 1 g per hour throughout the day. Uterine curettage is also a possible measure of reducing blood pressure in women with pre-eclampsia.

Uterine curettage reduced blood pressure in pre-eclamptic patients, but without adequate reporting of harms of perforation and infection dissemination, so it cannot currently be recommended. However, curettage should be done during a caesarean section of women with preeclampsia.

The own case of a systemic inflammatory response syndrome that occurred in a postpartum woman with mild pre-eclampsia is given. Postpartum endomyometritis, which was caused by group B streptococcus, should have played a triggering role in the progression of preeclampsia. The problem of polychemical resistance has led to the inability of traditional antimicrobial agents to prevent the dissemination of infection after curettage. The systemic inflammatory response syndrome has contributed to the increased severity of preeclampsia and the development of multiple organ failure.

Key words: preeclampsia, postpartum period, antihypertensive drugs.

REFERENCES

1. ACOG Committee Opinion 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol. 133(2):409-412. 2019. https://doi.org/10.1097/AOG.0000000000003082; PMid:30681541

2. Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 118(5):1102–7. 2011. https://doi.org/10.1097/AOG.0b013e318231934c; PMid:21979459

3. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 122(5):1122–31. 2013.

4. Ann-Charlotte I. 2013. Inflammatory mechanisms in preeclampsia. Pregnancy Hypertens. 3(2):58. https://doi.org/10.1016/j.preghy.2013.04.005; PMid:26105840

5. Bigelow CA, Pereira GA, Warmsley A, Cohen J, Getrajdman C, Moshier E, Paris J, Bianco A, Factor SH, Stone J. 2014. Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsia. Am J Obstet Gynecol. 210(4):338 e1–8. https://doi.org/10.1016/j.ajog.2013.11.004; PMid:24211478

6. Brien ME, Boufaied I, Soglio DD, Rey E, Leduc L, Girard S. 2019. Distinct inflammatory profile in preeclampsia and postpartum preeclampsia reveal unique mechanisms. Biol Reprod. 100(1):187-194. https://doi.org/10.1093/biolre/ioy164; PMid:30010720

7. Burgess A, McDowell W, Ebersold S. 2019. Association Between Lactation and Postpartum Blood Pressure in Women with Preeclampsia. MCN Am J Matern Child Nurs. 44(2):86-93. https://doi.org/10.1097/NMC.0000000000000502; PMid:30688668

8. Cairns AE, Pealing L, Duffy JMN et al. 2017. Postpartum management of hypertensive disorders of pregnancy: Late postpartum eclampsia. J Obstet Gynaecol. 32(3):264–6. a systematic review. BMJ Open 7:e018696. 2012. https://doi.org/10.1136/bmjopen-2017-018696; PMid:29187414 PMCid:PMC5719299

9. Clark TP. 2014. Late-onset postpartum preeclampsia: a case study. The Nurse practitioner 39(7): 34–42. https://doi.org/10.1097/01.NPR.0000443230.18099.e9; PMid:24932793

10. Cohen J, Vaiman D, Sibai BM, Haddad B. 2015. Blood pressure changes during the first stage of labor and for the prediction of early postpartum preeclampsia: a prospective study. European journal of obstetrics, gynecology, and reproductive biology 184:103–7. https://doi.org/10.1016/j.ejogrb.2014.11.020; PMid:25483991

11. Ditisheim A, Sibai B, Tatevian N. 2019, Jul 2. Placental Findings in Postpartum Preeclampsia: A Comparative Retrospective Study. Am J Perinatol. https://doi.org/10.1055/s-0039-1692716; PMCid:PMC7008975. Epub ahead of print.

12. Jääskeläinen T, Heinonen S, Hämäläinen E, Pulkki K, Romppanen J, Laivuori H. 2019. FINNPEC. Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort. Int J Obes (Lond). 43(5):1070-1081. https://doi.org/10.1038/s41366-018-0217-8; PMid:30254363

13. Janzarik WG, Jacob J, Katagis E, Markfeld-Erol F, Sommerlade L, Wuttke M, Reinhard M. 2019. Preeclampsia postpartum: Impairment of cerebral autoregulation and reversible cerebral hyperperfusion. Pregnancy Hypertens. 17:121-126. https://doi.org/10.1016/j.preghy.2019.05.019; PMid:31487628

14. Kalafat E, Thilaganathan B. 2017. Cardiovascular origins of preeclampsia. Curr Opin Obstet Gynecol. 29(6):383-389. https://doi.org/10.1097/GCO.0000000000000419; PMid:28961633

15. Lakhno IV. 2018. Systemic Inflammatory Response Syndrome as a Reason for the Multiple Organ Failure in a Postpartum Pre-eclamptic Patient. J South Asian Feder Obst Gynaecol. 10(3):215-217. https://doi.org/10.5005/jp-journals-10006-1592

16. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. 2004. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 190(5):1464–6. https://doi.org/10.1016/j.ajog.2004.02.037; PMid:15167870

17. Mc Lean G, Reyes O, Velarde R. 2017. Effects of postpartum uterine curettage in the recovery from Preeclampsia/Eclampsia. A randomized, controlled trial. Pregnancy Hypertens. 10:64-69. https://doi.org/10.1016/j.preghy.2017.06.001; PMid:29153692

18. Odigboegwu O, Pan LJ, Chatterjee P. 2018. Use of Antihypertensive Drugs During Preeclampsia. Front Cardiovasc Med. 5:50. https://doi.org/10.3389/fcvm.2018.00050; PMid:29896480 PMCid:PMC5987086

19. Skurnik G, Hurwitz S, McElrath TF, Tsen LC, Duey S, Saxena AR, Karumanchi A, Rich-Edwards JW, Seely EW. 2017. Labor therapeutics and BMI as risk factors for postpartum preeclampsia: A case-control study. Pregnancy Hypertens. 10:177-181. https://doi.org/10.1016/j.preghy.2017.07.142; PMid:29153674 PMCid:PMC5747249

20. Smith GN, Pudwell J, Saade GR. 2019. Impact of the New American Hypertension Guidelines on the Prevalence of Postpartum Hypertension. Am J Perinatol. 36(4):440-442. https://doi.org/10.1055/s-0038-1669441; PMid:30170330

21. Takaoka S, Ishii K, Taguchi T, Kakubari R, Muto H, Mabuchi A, Yamamoto R, Hayashi S, Mitsuda N. 2016. Clinical features and antenatal risk factors for postpartum-onset hypertensive disorders. Hypertens Pregnancy: 1–10. https://doi.org/10.3109/10641955.2015.1100308; PMid:26828093

22. Too G, Wen T, Boehme AK, Miller EC, Leffert  LR, Attenello FJ, Mack WJ, DʼAlton ME, Friedman AM. 2018. Timing and Risk Factors of Postpartum Stroke. Obstet Gynecol. 131(1):70-78. https://doi.org/10.1097/AOG.0000000000002372; PMid:29215510 PMCid:PMC6402829

23. Verhaegen J, Peeters F, Debois P, Jacquemyn Y. 2019. Posterior reversible encephalopathy syndrome as a complication of pre-eclampsia in the early postpartum period. BMJ Case Rep. 12(7). pii: e228954. https://doi.org/10.1136/bcr-2018-228954; PMid:31315841

24. Yancey LM, Withers E, Bakes K, Abbott J. 2011. Postpartum preeclampsia: emergency department presentation and management. The Journal of emergency medicine 40(4):380–4. https://doi.org/10.1016/j.jemermed.2008.02.056; PMid:18814997